GLP 1 agonist may interfere with the body’s reward system
Short excerpt from a YouTube video (Dr. Ron Najafi, uploaded June 26, 2024) arguing that GLP-1 agonists may disrupt the body’s reward system and listing associated adverse effects: depression, delayed gastric emptying (gastroparesis), nausea, vomiting, dehydration. The speaker characterizes interference with the reward system as "dicey" and reports gastroparesis as a relatively rare (~1–2%) but potentially persistent effect.
Questions this video answers
About 1–2% (speaker's claim).
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet